Release Summary

Class action securities fraud litigation has been brought on behalf of investors in Horizon Pharma PLC (Nasdaq: HZNP) between March 13, 2014 and February 26, 2016, inclusive.

Lieff Cabraser Heimann & Bernstein, LLP